Corpus Intelligence IC Memo — MULTICARE COVINGTON MEDICAL CENTER 2026-04-26 12:36 UTC
IC Memo — MULTICARE COVINGTON MEDICAL CENTER
Investment Committee Memorandum | WA | 45 beds | Grade C | EBITDA uplift $7.2M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

MULTICARE COVINGTON MEDICAL CENTER

CCN 500154 | KING, WA | 45 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

MULTICARE COVINGTON MEDICAL CENTER is a 45-bed suburban community hospital in KING, WA with $97.2M in net patient revenue and a -2.2% operating margin. The hospital serves a payer mix of 22.4% Medicare, 1.5% Medicaid, and 76.2% commercial.

Thesis: Turnaround. Our ML models identify $7.2M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -2.2% to 5.2% (+736bps).

Net Revenue HCRIS$97.2M
Current EBITDA COMPUTED$-2.1M
Operating Margin COMPUTED-2.2%
Occupancy HCRIS72.5%
Revenue / Bed COMPUTED$2.2M
Net-to-Gross HCRIS25.2%
Distress Probability ML40.0%

2. Market Context & Competitive Position

104
WA Hospitals
-10.3%
State Median Margin
40
Comparable Hospitals

WA has 104 Medicare-certified hospitals with a median operating margin of -10.3%. The target's margin of -2.2% places it above the state median. Among 40 size-comparable peers (22-90 beds), the median margin is -9.0%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (22-90), prioritizing same-state peers. 40 hospitals in the comp set.

HospitalStateBedsRevenueMargin
MULTICARE COVINGTON MEDICAL CE (Target)WA45$97.2M-2.2%
OLYMPIC MEDICAL CENTERWA78$237.9M-12.2%
MULTICARE AUBURN MEDICAL CENTEWA84$214.7M-21.1%
JEFFERSON GENERAL HOSPITALWA25$148.0M-3.0%
SAMARITAN HOSPITALWA48$137.4M-4.1%
MASON GENERAL HOSPITALWA25$127.1M-5.3%
KITTITAS VALLEY COMMUNITY HOSPWA25$121.0M2.3%
TRI-STATE MEMORIAL HOSPITALWA25$107.0M0.8%
ISLAND HOSPITALWA43$106.1M-15.0%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $7.2M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$2.0M+210bp18mo
Cost to Collect4.5%2.5%$1.9M+200bp12mo
Denial Rate Reduction12.0%6.5%$1.9M+198bp12mo
A/R Days Reduction5200.0%3800.0%$1.2M+122bp9mo
Clean Claim Rate88.0%96.0%$62K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$2.0M
Cost to Collect
$1.9M
Denial Rate Reduction
$1.9M
A/R Days Reduction
$1.2M
Clean Claim Rate
$62K
Total EBITDA Uplift$7.2M
Current EBITDA$-2.1M
+ RCM Uplift+$7.2M
Pro Forma EBITDA$5.1M
Current Margin-2.2%
Pro Forma Margin5.2%
WC Released (1x)$3.7M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-3.2M$57.7M0.00x-100.0%
Base (11x exit)10.0x11.0x$-3.2M$62.4M0.00x-100.0%
Bull Case9.0x11.0x$-2.9M$84.9M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-2.9M$91.8M0.00x-100.0%
Bear Case11.0x10.0x$-3.6M$22.9M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-3.6M$24.1M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 40 hospitals with 22-90 beds
  • Same-state prioritization (n=41)
  • Comp margins: P25=-13.3% / P50=-9.0% / P75=-3.8%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.